title: McClellan's FDA: boon to industry, consumers, or both?     New FDA chief plans to speed drug approval and reduce costs.
authors.forename: Alicia
authors.initials: A
authors.lastname: Ault
mesh_terms: D000288:Administrative Personnel; D001709:Biotechnology / Q000379:methods; D003255:Consumer Organizations; D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000379:methods; D006801:Humans; D008119:Lobbying; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence / Q000458:organization & administration*